Drugs / IDOlong
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02077114 | Feb → Sep 2014 | metastatic melanoma | Herlev Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDOlong | “All patients will receive seven vaccines containing IDOlong” NCT02077114 ↗ |